Symbol="CHRS"
AssetType="Common Stock"
Name="Coherus BioSciences Inc"
Description="Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. The company is headquartered in Redwood City, California."
CIK="1512762"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="442585000"
EBITDA="-234919008"
PERatio="None"
PEGRatio="0"
BookValue="-2.441"
DividendPerShare="0"
DividendYield="0"
EPS="-3.59"
RevenuePerShareTTM="2.347"
ProfitMargin="-1.48"
OperatingMarginTTM="-1.302"
ReturnOnAssetsTTM="-0.3"
ReturnOnEquityTTM="-16.57"
RevenueTTM="183363000"
GrossProfitTTM="-58399000"
DilutedEPSTTM="-3.59"
QuarterlyEarningsGrowthYOY="-0.755"
QuarterlyRevenueGrowthYOY="-0.46"
AnalystTargetPrice="13.75"
TrailingPE="-"
ForwardPE="32.89"
PriceToSalesRatioTTM="2.354"
PriceToBookRatio="73.19"
EVToRevenue="3.202"
EVToEBITDA="-3.109"
Beta="0.887"
num_52WeekHigh="14.11"
num_52WeekLow="3.6"
num_50DayMovingAverage="4.53"
num_200DayMovingAverage="6.82"
SharesOutstanding="94468000"
DividendDate="None"
ExDividendDate="None"
symbol="CHRS"
open="4.64"
high="4.83"
low="4.60"
price="4.79"
volume="2613172.00"
latest_trading_day="2023-07-28"
previous_close="4.60"
change="0.19"
change_percent="4.1304%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="80"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="20"
Volume_recent_avg="2623022"
Change_recent_avg="-0.03"
Delta_recent_avg="0.41"
Variance_recent_avg="0.21"
Change_ratio_recent_avg="-0.67"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="20"
Aroon_momentum_negative="80"
image_negative_thumbnail_id_1="1155"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0189.jpeg"
image_negative_thumbnail_id_2="167"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0009.jpeg"
image_neutral_thumbnail_id_1="538"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_neutral_thumbnail_id_2="432"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_positive_thumbnail_id_1="972"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0134.jpeg"
image_positive_thumbnail_id_2="682"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0026.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
